4Catalyzer

4Catalyzer is a pioneering brand at the forefront of transforming 21st-century medicine and addressing the most pressing challenges in the life sciences, medical devices, therapeutics, artificial intelligence, and the environment. Founded by renowned scientist and entrepreneur Dr. Jonathan Rothberg, the brand is dedicated to democratizing medicine and bringing life-saving technologies to the masses.

4Catalyzer operates as an incubator for companies that leverage cutting-edge technologies to revolutionize healthcare. Its portfolio includes groundbreaking ventures such as Butterfly Network, Quantum-Si, Hyperfine Research, Detect, Tesseract Health, AI Therapeutics, and Protein Evolution Inc. These companies utilize game-changing advancements like deep learning, next-generation sequencing, and advancements in the silicon supply chain to tackle global healthcare obstacles.

With over 500 team members and securing more than $2 billion in funding, 4Catalyzer is shaping the future of medicine. Driven by a personal passion for improving lives, Jonathan Rothberg and the brand are dedicated to creating a profound impact on society. Through their innovative solutions and unwavering commitment, 4Catalyzer is revolutionizing the way we approach healthcare and changing the world for the better